Malignant or benign tumors of the lung
Conditions
Interventions
Experimental group:Intercostal nerve block was performed with ropivacaine and methylprednisolone three days after surgery
Control group:Normal saline
Sponsors
Chongqing University Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Adult patients aged 18-70 years; 2. Patients diagnosed with benign or malignant lung tumors who are expected to undergo single-hole thoracoscopic surgery without surgical contraindications; 3. ASA grade I-?; 4. All surgical patients signed informed consent.
Exclusion criteria
Exclusion criteria: 1. A history of opioid allergy or abuse; 2. Allergic patients with ropivacaine or methylprednisolone; 3. Patients with chronic pain, long-term or ongoing use of analgesic drugs; 4. Long-term or current users of hormones; 5. Patients who cannot understand the meaning of pain score; 6. Preoperative and intraoperative decisions were made to bring the patients back to ICU after surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score;Burst pain;Number of opioid analgesics used;PaO2/FiO2;Postoperative pulmonary infection;Postoperative atelectasis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative active time to get out of bed;Postoperative hospital stay; | — |
Countries
China
Contacts
Public ContactCai Huarong
Chongqing University Cancer Hospital
Outcome results
None listed